|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | |||||||||||
| Current assets: | |||||||||||
| Cash | |||||||||||
| Prepaid expenses | |||||||||||
| Total current assets | |||||||||||
| Cash and investments held in Trust Account | |||||||||||
| Total assets | |||||||||||
| Current liabilities: | |||||||||||
| Accrued expenses, formation and offering costs | |||||||||||
| Accrued expenses | |||||||||||
| State franchise tax accrual | |||||||||||
| Warrants derivative liability | |||||||||||
| Public Warrants | |||||||||||
| Private Placement Warrants | |||||||||||
| Income tax payable | |||||||||||
| Notes payable - related party | |||||||||||
| Total current liabilities | |||||||||||
| Liabilities Noncurrent | |||||||||||
| Warrants derivative liability | |||||||||||
| Public Warrants | |||||||||||
| Private Placement Warrants | |||||||||||
| Deferred income tax payable | |||||||||||
| Deferred underwriting compensation | |||||||||||
| Total liabilities | |||||||||||
| Class A Common Stock subject to possible redemption, 6,029,977 shares at September 30, 2024 and 52,500,000 shares at December 31, 2023 (at redemption value of $10.07 and $10.51 per share, respectively, par value $10.00) | |||||||||||
| Stockholders' deficit: | |||||||||||
| Common stock value | |||||||||||
| Accumulated deficit | |||||||||||
| Total stockholders' deficit | |||||||||||
| Total liabilities and stockholders' deficit |
Loading...
